Quantum Cyber N.V. (QUCY) Cash Flow Statement

NASDAQ: QUCYOperating cash, capex, free cash flow and buybacks.

Where QUCY’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$11.0M
Capital expenditures
$1.1M
195.7% of revenue
Free cash flow
−$12.0M
−2,240.0% margin
Returned to shareholders
—
Change in cash
−$5.3M
cash at year-end $889,091
Shares issued: $8.2MShares issued$8.2MDrawn from cash: $5.3MDrawn from cash$5.3MCash used in operations: $11.0MCash used in operations$11.0M · 81%Debt repayment: $1.2MDebt repayment$1.2M · 9%Capital expenditures: $1.1MCapital expenditures$1.1M · 8%Other financing, Currency & other: $322,221Other uses$322,221 · 2%$13.6M
Cash from operations
−$11.0M
Capital expenditures
−$1.1M
Net borrowing (repayment)
−$1.2M
Shares issued
+$8.2M
Other financing
−$243,405
Currency & other
−$78,816
Change in cash
−$5.3M

Drawn to scale: where the cash came from and how it was used. Hover for values.

QUCY operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

QUCY cash flow trends, 2021–2025

Quantum Cyber N.V. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$3.2M2021−$11.0M2025—
Capital expenditures$16,7052021$1.1M2025+181.7%/yr
Free cash flow−$3.2M2021−$12.0M2025—
Free cash flow margin−560.7%2021−2,240.0%2025−1,679.4 pts
Stock-based compensation$6.4M2021$2.7M2025−19.7%/yr
Capex / revenue2.9%2021195.7%2025+192.8 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

QUCY cash flow by activity

OperatingInvestingFinancingChange in cash

QUCY net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

QUCY cash flow statement

Quantum Cyber N.V. annual cash flow statement
20252024202320222021
Operating activities
Net income−$16.2M−$21.7M−$26.3M−$26.4M−$11.7M
Depreciation & amortization$615,720$1.0M$866,412$379,798$69,929
Stock-based compensation$2.7M$1.1M$4.0M$9.8M$6.4M
Change in working capital−$1.6M$51,746−$64,630$1.4M−$138,616
Other non-cash items$3.6M$2.4M−$450,529$26,785$2.1M
Cash from operating activities−$11.0M−$17.1M−$21.9M−$14.8M−$3.2M
Investing activities
Capital expenditures−$1.1M−$254,949−$1.9M−$658,483−$16,705
Acquisitions & other investing$17,815$56,132$0$0$1.2M
Cash from investing activities−$1.0M−$198,817−$1.9M−$658,483$1.2M
Financing activities
Net borrowing (repayment)−$1.2M$2.8M$7.8M−$304,971$185,374
Shares issued$8.2M$13.8M$6.4M$23.9M$10.4M
Other financing−$243,405$0$0$382,500$0
Cash from financing activities$6.8M$16.6M$14.2M$23.9M$10.6M
Summary
Net change in cash−$5.3M−$835,255−$10.1M$8.4M$8.6M
Cash at end of period$889,091$6.2M$7.1M$17.1M$8.7M
Free cash flow−$12.0M−$17.3M−$23.8M−$15.4M−$3.2M
Free cash flow margin−2,240.0%−1,940.2%−2,662.0%−2,911.6%−560.7%
Capex / revenue195.7%28.5%212.0%124.3%2.9%

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

QUCY cash generation

In fiscal 2025 (ended December 31, 2025), Quantum Cyber generated -$11.0 million of cash from operations and spent $1.1 million on capital expenditures, leaving free cash flow of -$12.0 million, −2,240.0% of revenue. Cash and equivalents fell by $5.3 million over the year.

Related: QUCY income statement, QUCY balance sheet. See the QUCY stock overview for the latest quote and news.

QUCY cash flow FAQ

What is Quantum Cyber's free cash flow?

Quantum Cyber's free cash flow was -$12.0 million in fiscal 2025: -$11.0 million of operating cash flow minus $1.1 million of capital expenditures It was -$17.3 million a year earlier..

How much cash does Quantum Cyber generate from operations?

Quantum Cyber generated -$11.0 million of cash from operating activities in fiscal 2025.

How much does Quantum Cyber spend on capital expenditures?

Quantum Cyber spent $1.1 million on capital expenditures in fiscal 2025, 195.7% of revenue, compared with $0.3 million the year before.

Diagnostics & Research: cash flow